23andme glp-1 Unlocking the Genetics of Medications Through Crowdsourced Science at GLP-1 Articles | 23andMe Blog
Description
Clinically Enhanced Benefits & Key Bioactive Pathways
How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors
These medications work by mimicking the action of GLP-1, thereby helping to regulate blood sugar levels and reduce appetite
88% reduced sugar cravings
8 AAFP CME credits
